WIN 55,212-2

From WikiMD's WELLNESSPEDIA

WIN 55,212-2 is a chemical compound that is often used in scientific research. It is a synthetic cannabinoid and a potent agonist that binds to cannabinoid receptors in the body. WIN 55,212-2 is known for its ability to mimic the effects of naturally occurring cannabinoids, such as tetrahydrocannabinol (THC), the active compound in cannabis.

Chemical Structure and Properties[edit]

WIN 55,212-2 is a derivative of naphthalen-1-yl-(1-pentylindol-3-yl)methanone. It has a molecular formula of C27H26O3 and a molecular weight of 426.49 g/mol. The compound is usually presented as a racemic mixture, with the (R)-enantiomer being the active form.

Pharmacology[edit]

WIN 55,212-2 acts as a full agonist at the CB1 receptor and has a high affinity for the CB2 receptor. The compound's effects are similar to those of other cannabinoids, such as analgesia, anti-inflammatory effects, and appetite stimulation. However, it also has some unique properties, such as neuroprotective effects, which have been studied in the context of conditions like Alzheimer's disease and Parkinson's disease.

Research and Clinical Use[edit]

While WIN 55,212-2 is not used clinically, it is widely used in research due to its potent and selective activity at the cannabinoid receptors. Studies have investigated its potential therapeutic effects in a range of conditions, including neurodegenerative diseases, pain, inflammation, and cancer. However, more research is needed to fully understand the potential therapeutic applications of this compound.

Safety and Side Effects[edit]

As with other cannabinoids, the use of WIN 55,212-2 can lead to a range of side effects, including dizziness, nausea, and changes in mood. However, these effects are generally mild and transient. The safety profile of WIN 55,212-2 in humans has not been fully established, as most of the research on this compound has been conducted in animal models.

See Also[edit]

This article is a stub related to chemistry. You can help WikiMD by expanding it!


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


  • WIN 55,212-2 2D Skeletal Structure
    WIN 55,212-2 2D Skeletal Structure
  • Pancreatic Stellate Cell
    Pancreatic Stellate Cell

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=WIN_55,212-2&oldid=6311079"